| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046314 Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |
| 04/04/2000 | US6046035 Polynucleotides encoding a cardiotrophin-like cytokine |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046024 Method of producing a fibrin monomer using a biotinylated enzyme and immobilized avidin |
| 04/04/2000 | US6046011 Mammalian adrenocorticotropic hormone receptors and uses |
| 04/04/2000 | US6046009 Diagnosis and treatment of glaucoma |
| 04/04/2000 | US6045999 Transcription factor E2F-4 |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045807 Method for production of neuroblasts |
| 04/04/2000 | US6045803 Administering to an avian a recombinant herpesvirus of turkeys for expressing an antigenic polypeptide to treat viral diseases |
| 04/04/2000 | US6045802 Antitumor agents treating cancer |
| 04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
| 04/04/2000 | US6045795 Methods and compositions for ameliorating the symptoms of sepsis |
| 04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
| 04/04/2000 | CA2048676C Artificial promoter for the expression of proteins in yeast |
| 04/04/2000 | CA2045475C Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay |
| 04/04/2000 | CA2034425C Method for inhibiting bacteria using a novel lactococcal bacteriocin |
| 04/04/2000 | CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained |
| 03/30/2000 | WO2000017648A1 Apoptosis marker antibodies and methods of use |
| 03/30/2000 | WO2000017383A1 Factor v leiden detection |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
| 03/30/2000 | WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017362A1 Human interleukin-b50, therapeutic uses |
| 03/30/2000 | WO2000017361A2 Interferon-epsilon |
| 03/30/2000 | WO2000017358A2 Human chaperone proteins |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017353A1 Ucp4 |
| 03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017350A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017337A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 03/30/2000 | WO2000017237A1 Cerebral organic anion transporter and its gene |
| 03/30/2000 | WO2000017235A2 Cytokine receptor zalpha11 |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | WO2000016803A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 03/30/2000 | WO2000016631A1 Murf2 |
| 03/30/2000 | WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 03/30/2000 | WO2000000609A3 Molecules associated with apoptosis |
| 03/30/2000 | WO1999067393A3 Aav scleroprotein, production and use thereof |
| 03/30/2000 | WO1999064593A3 Cell cycle regulation proteins |
| 03/30/2000 | WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof |
| 03/30/2000 | WO1999057565A3 Methods for diagnosing and evaluating cancer |
| 03/30/2000 | WO1999042477A3 Transporter protein for saccharide-coupled medicaments |
| 03/30/2000 | CA2344699A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 03/30/2000 | CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/30/2000 | CA2343090A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/30/2000 | CA2342783A1 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 03/30/2000 | CA2342773A1 Interferon-epsilon |
| 03/30/2000 | CA2339866A1 Recombinant celo virus and celo virus dna |
| 03/29/2000 | EP0988390A1 Alternatively targeted adenovirus |
| 03/29/2000 | EP0988381A1 T-cell receptor beta-like protein |
| 03/29/2000 | EP0988380A1 Translational regulator initiation factor 4e-binding protein |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988376A2 Noey2 gene compositions and methods of use |
| 03/29/2000 | EP0988371A1 Human tumor necrosis factor receptor tr9 |
| 03/29/2000 | EP0988319A1 Human l105 proteins and polynucleotides encoding same |
| 03/29/2000 | EP0988318A2 Human extracellular matrix proteins |
| 03/29/2000 | EP0988317A2 Aib1, a steroid receptor co-activator |
| 03/29/2000 | EP0988316A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 03/29/2000 | EP0988047A1 Soluble ctla4 mutant molecules and uses thereof |
| 03/29/2000 | CN1248631A Fusion protein for immunoprophyaxis and immunotherapy of venereal disease and cancer |
| 03/29/2000 | CN1248626A Novel human gene coding sequence, its coded polypeptide and preparation process thereof |
| 03/29/2000 | CN1248625A Novel human gene coding sequence, its coded polypeptide and preparation process thereof |
| 03/29/2000 | CN1248624A Novel human capside protein subunit coding sequence, its coded polypeptide and preparation process |
| 03/29/2000 | CN1050862C Method for human urokinase and other useful proteins efficiently demonstrated by insect cells |
| 03/28/2000 | US6043346 Antibody that binds to a tub polypeptide |
| 03/28/2000 | US6043343 Amino acid sequence; for diagnosis and prevention of cancer and tumors; anticarcinogenic/antitumor agents; for screening compounds which bind to polypeptide |
| 03/28/2000 | US6043220 Threonine-containing protegrins |
| 03/28/2000 | US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited |
| 03/28/2000 | US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides |
| 03/28/2000 | US6043071 GlmU |
| 03/28/2000 | US6043058 Preparation of cyclic depsipeptide compounds and a novel cyclic depsipeptide |
| 03/28/2000 | US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders |
| 03/28/2000 | US6043054 Polynucleotides encoding a novel GABA BP polypeptide |
| 03/28/2000 | US6043053 Wnt-3 polynucleotides |
| 03/28/2000 | US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents |
| 03/28/2000 | US6042835 Prototype FelV isolates for use in disease models and vaccines |
| 03/28/2000 | US6042831 Epitopes of the hiv virus gp160 protein, is immunologically homologous to epitopes of the protein family of the human major histocompatiblity complex, used for diagnosis and immunization |
| 03/28/2000 | US6042828 Humanized antibodies to ganglioside GM2 |
| 03/28/2000 | US6042827 Anti-idiotypic antibody induction of anti-tumor response |
| 03/28/2000 | US6042826 Administering intrathecally or intralesionally a therapeutically effective amount of a fas-crosslinking component selected from an agonsit antihuman fas monoclonal antibody, anti-human fas bid fragments, or soluble fas-ligand |
| 03/28/2000 | CA2140531C Method of increasing expression of viral proteins |
| 03/28/2000 | CA2023094C Efficient production of mutant proteases |
| 03/28/2000 | CA2022420C Escherichia coli vaccine |
| 03/28/2000 | CA2008735C Human epidermal growth factor (egf) receptor sequences and egf competitive monoclonal antibodies |
| 03/28/2000 | CA2004885C Anticoagulant peptides |
| 03/28/2000 | CA1340935C Fc gamma receptor |